Literature DB >> 12767411

A comparison between traditional methods and multilevel regression for the analysis of multicenter intervention studies.

Mirjam Moerbeek1, Gerard J P van Breukelen, Martijn P F Berger.   

Abstract

This article reviews three traditional methods for the analysis of multicenter trials with persons nested within clusters, i.e., centers, namely naïve regression (persons as units of analysis), fixed effects regression, and the use of summary measures (clusters as units of analysis), and compares these methods with multilevel regression. The comparison is made for continuous (quantitative) outcomes, and is based on the estimator of the treatment effect and its standard error, because these usually are of main interest in intervention studies. When the results of the experiment have to be valid for some larger population of centers, the centers in the intervention study have to present a random sample from this population and multilevel regression may be used. It is shown that the treatment effect and especially its standard error, are generally incorrectly estimated by the traditional methods, which should, therefore, not in general be used as an alternative to multilevel regression.

Entities:  

Mesh:

Year:  2003        PMID: 12767411     DOI: 10.1016/s0895-4356(03)00007-6

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  33 in total

1.  Estimating and reporting on the quality of inpatient stroke care by Veterans Health Administration Medical Centers.

Authors:  Greg Arling; Mathew Reeves; Joseph Ross; Linda S Williams; Salomeh Keyhani; Neale Chumbler; Michael S Phipps; Christianne Roumie; Laura J Myers; Amanda H Salanitro; Diana L Ordin; Jennifer Myers; Dawn M Bravata
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Social disadvantage and schizophrenia. A combined neighbourhood and individual-level analysis.

Authors:  Marjan Drukker; Lydia Krabbendam; Ger Driessen; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-02       Impact factor: 4.328

Review 3.  Analytic complexities associated with group therapy in substance abuse treatment research: problems, recommendations, and future directions.

Authors:  Antonio A Morgan-Lopez; William Fals-Stewart
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

4.  Using a hierarchical model to estimate risk-adjusted mortality for hospitals not included in the reference sample.

Authors:  David E Clark; Edward L Hannan; Stephen W Raudenbush
Journal:  Health Serv Res       Date:  2010-01-08       Impact factor: 3.402

5.  The Impact of Ignoring the Level of Nesting Structure in Nonparametric Multilevel Latent Class Models.

Authors:  Jungkyu Park; Hsiu-Ting Yu
Journal:  Educ Psychol Meas       Date:  2015-11-26       Impact factor: 2.821

6.  Predicting risk-adjusted mortality for trauma patients: logistic versus multilevel logistic models.

Authors:  David E Clark; Edward L Hannan; Chuntao Wu
Journal:  J Am Coll Surg       Date:  2010-07-01       Impact factor: 6.113

7.  Multilevel interventions: study design and analysis issues.

Authors:  Paul D Cleary; Cary P Gross; Alan M Zaslavsky; Stephen H Taplin
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

8.  A solution to dependency: using multilevel analysis to accommodate nested data.

Authors:  Emmeke Aarts; Matthijs Verhage; Jesse V Veenvliet; Conor V Dolan; Sophie van der Sluis
Journal:  Nat Neurosci       Date:  2014-03-26       Impact factor: 24.884

9.  Modeling site effects in the design and analysis of multi-site trials.

Authors:  Daniel J Feaster; Susan Mikulich-Gilbertson; Ahnalee M Brincks
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

Review 10.  Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders.

Authors:  Katie Witkiewitz; John W Finney; Alex H S Harris; Daniel R Kivlahan; Henry R Kranzler
Journal:  Alcohol Clin Exp Res       Date:  2015-08-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.